Company Aarti Pharmalabs Limited

AARTIPHARM

INE0LRU01027

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 04:49:27 11/06/2026 pm IST			5-day change	1st Jan Change
622.35 ^INR	+0.02%		+0.08%	-17.28%

26/05	Aarti Pharmalabs Limited, Q4 2026 Earnings Call, May 26, 2026
26/05	Aarti Pharmalabs' Fiscal Q4 Consolidated Profit Slumps	MT

Business description: Aarti Pharmalabs Limited

Aarti Pharmalabs Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives, based in India. The Company also offers comprehensive contract development and manufacturing organization (CDMO) and CMO services for drug substances and new chemical entities (NCE), including their key starting materials (KSM) and regulatory starting materials (RSM), serving various pharmaceutical companies worldwide with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products. Its caffeine products include caffeine anhydrous, and caffeine anhydrous (granules). Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its products are exported to key regulated markets such as the United States (US), the European Union, and Japan.

Number of employees: 2,162

Sales by Activity: Aarti Pharmalabs Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Pharmeceuticals	-	1.2TCr	1.95TCr	1.85TCr	2.12TCr

See all business segments

Geographical breakdown of sales: Aarti Pharmalabs Limited

Fiscal Period: March	2021 (INR)	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)
Outside India	-	-	-	843.71Cr	1.22TCr
India	-	-	-	974.38Cr	868.87Cr
Unallocated	-	-	-	35Cr	27Cr

See all geographic segments

Executive Committee: Aarti Pharmalabs Limited

Manager	Title	Age	Since
Narendra Jagannath Salvi CEO	Chief Executive Officer	61	17/10/2022
Hetal Gogri Gala CEO	Chief Executive Officer	50	17/10/2022
Piyush Lakhani DFI	Director of Finance/CFO	-	17/10/2022
Bharat S. Patravale CTO	Chief Tech/Sci/R&D Officer	-	01/10/2022
Sudhakar Shetty ADM	Chief Administrative Officer	-	-

See AARTI PHARMALABS LIMITED governance

Composition of the Board of Directors: Aarti Pharmalabs Limited

Director	Title	Age	Since
Hetal Gogri Gala BRD	Director/Board Member	50	17/10/2022
Rajendra Vallabhaji Gogri BRD	Director/Board Member	66	07/08/2021
Rashesh Chandrakant Gogri CHM	Chairman	52	01/01/2022
Narendra Jagannath Salvi BRD	Director/Board Member	61	17/10/2022
Jeenal Kenil Savla BRD	Director/Board Member	-	-
Chandrakant V. Gogri BRD	Director/Board Member	79	-
Parimal Hasmukhlal Desai BRD	Director/Board Member	76	-
Vinay Gopal Nayak BRD	Director/Board Member	69	17/10/2022
Rupal Anand Vora BRD	Director/Board Member	63	-
Vilas Gajanan Gaikar BRD	Director/Board Member	65	-

Composition of the Board of Directors

Shareholders: Aarti Pharmalabs Limited

Name	Stocks	%	Valuation
Life Insurance Corporation of India (Investment Portfolio) 5.275 %	47,82,452	5.275 %	32 M ₹
Rashesh Chandrakant Gogri 4.23 %	38,34,404	4.23 %	26 M ₹
Jaya Chandrakant Gogri 3.535 %	32,04,310	3.535 %	21 M ₹
Anushakti Enterprise Private Ltd. 3.301 %	29,92,950	3.301 %	20 M ₹
Labdhi Business Trust 3.134 %	28,41,504	3.134 %	19 M ₹

List of AARTI PHARMALABS LIMITED shareholders

Company details: Aarti Pharmalabs Limited

Aarti Pharmalabs Ltd.

Embassy Park 247

400083, Mumbai

+91 22 6943 6100

http://www.aartipharmalabs.com

address Aarti Pharmalabs Limited(AARTIPHARM)

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AARTI PHARMALABS LIMITED	+0.02%	+0.08%	-32.61%	+57.72%	59Cr
ELI LILLY AND COMPANY	+2.65%	+3.71%	+44.32%	+162.07%	1,01300Cr
JOHNSON & JOHNSON	+0.86%	+5.51%	+55.06%	+50.56%	57TCr
ABBVIE INC.	+0.59%	+0.64%	+18.21%	+64.37%	40TCr
ROCHE HOLDING AG	-0.37%	+4.97%	+21.24%	+15.95%	32TCr
ASTRAZENECA PLC	+0.81%	+0.21%	+24.54%	+14.81%	28TCr
NOVARTIS AG	+2.07%	+5.23%	+25.67%	+34.19%	27TCr
AMGEN INC.	+3.36%	+0.96%	+19.57%	+60.53%	18TCr
NOVO NORDISK A/S	-0.19%	-0.46%	-45.32%	-48.35%	19TCr
GILEAD SCIENCES, INC.	+3.48%	-2.42%	+15.32%	+61.89%	15TCr
Average	+1.31%	+2.39%	+14.60%	+47.37%	33.89TCr
Weighted average by Cap.	+1.49%	+3.99%	+29.97%	+73.32%